In NSCLC, TBK1 is a key factor in the KRAS-induced oncogenic transformation of mouse embryonic fibroblasts; the activation of TBK1 by upstream signaling inhibits the apoptosis of cancer cells [130]. Here, KRAS is linked to cancer.